Intra-Cellular Therapies, Inc. (ITCI)
USD 131.87
(0.0%)
USD 131.87
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.46 USD | 46.32% |
| 2022 | -2.72 USD | 22.29% |
| 2021 | -3.50 USD | -8.36% |
| 2020 | -3.23 USD | -20.52% |
| 2019 | -2.68 USD | 5.63% |
| 2018 | -2.84 USD | -33.96% |
| 2017 | -2.12 USD | 21.19% |
| 2016 | -2.69 USD | 7.56% |
| 2015 | -2.91 USD | -171.96% |
| 2014 | -1.07 USD | 31.41% |
| 2013 | -1.56 USD | -108.0% |
| 2012 | -0.75 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.16 USD | 46.67% |
| 2024 Q3 | -0.25 USD | -56.25% |
| 2024 Q2 | -0.16 USD | 0.0% |
| 2023 Q4 | -0.30 USD | -20.0% |
| 2023 FY | - USD | 46.32% |
| 2023 Q1 | -0.46 USD | -17.95% |
| 2023 Q2 | -0.45 USD | 2.17% |
| 2023 Q3 | -0.25 USD | 44.44% |
| 2022 FY | - USD | 22.29% |
| 2022 Q4 | -0.39 USD | 31.58% |
| 2022 Q3 | -0.57 USD | 35.96% |
| 2022 Q2 | -0.89 USD | -14.1% |
| 2022 Q1 | -0.78 USD | 25.71% |
| 2021 Q4 | -1.05 USD | -10.53% |
| 2021 Q3 | -0.95 USD | -11.76% |
| 2021 FY | - USD | -8.36% |
| 2021 Q1 | -0.65 USD | 14.47% |
| 2021 Q2 | -0.85 USD | -30.77% |
| 2020 Q1 | -0.73 USD | 0.0% |
| 2020 FY | - USD | -20.52% |
| 2020 Q2 | -0.96 USD | -31.51% |
| 2020 Q3 | -0.79 USD | 17.71% |
| 2020 Q4 | -0.76 USD | 3.8% |
| 2019 Q1 | -0.63 USD | 14.86% |
| 2019 Q4 | -0.73 USD | -15.87% |
| 2019 Q2 | -0.68 USD | -7.94% |
| 2019 Q3 | -0.63 USD | 7.35% |
| 2019 FY | - USD | 5.63% |
| 2018 Q4 | -0.74 USD | 2.63% |
| 2018 FY | - USD | -33.96% |
| 2018 Q3 | -0.76 USD | -11.76% |
| 2018 Q2 | -0.68 USD | -4.62% |
| 2018 Q1 | -0.65 USD | -16.07% |
| 2017 Q3 | -0.53 USD | -29.27% |
| 2017 Q2 | -0.41 USD | 33.87% |
| 2017 Q1 | -0.62 USD | 3.13% |
| 2017 FY | - USD | 21.19% |
| 2017 Q4 | -0.56 USD | -5.66% |
| 2016 Q4 | -0.64 USD | 8.57% |
| 2016 Q3 | -0.70 USD | 1.41% |
| 2016 FY | - USD | 7.56% |
| 2016 Q1 | -0.64 USD | 4.48% |
| 2016 Q2 | -0.71 USD | -10.94% |
| 2015 Q2 | -0.61 USD | 15.28% |
| 2015 FY | - USD | -171.96% |
| 2015 Q4 | -0.67 USD | 26.37% |
| 2015 Q3 | -0.91 USD | -49.18% |
| 2015 Q1 | -0.72 USD | -38.46% |
| 2014 Q4 | -0.52 USD | -136.36% |
| 2014 Q2 | -0.15 USD | 11.76% |
| 2014 Q3 | -0.22 USD | -46.67% |
| 2014 FY | - USD | 31.41% |
| 2014 Q1 | -0.17 USD | 43.33% |
| 2013 Q2 | -0.00 USD | 99.87% |
| 2013 Q3 | -0.22 USD | -43900.0% |
| 2013 Q1 | -0.39 USD | -85.71% |
| 2013 FY | - USD | -108.0% |
| 2013 Q4 | -0.30 USD | -36.36% |
| 2012 Q4 | -0.21 USD | 0.0% |
| 2012 FY | - USD | 0.0% |